We are live on
!
Find out more
IVLAV
Index Venture Life Associates VI Portfolio holdings
AUM
$396M
1-Year Est. Return
176.22%
This Fund
S&P 500
This Quarter
Est. Return
-32.57%
1 Year Est. Return
+176.22%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
–
Cap. Flow
+$134M
Cap. Flow
% of AUM
119.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
1
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CNTA
Centessa Pharmaceuticals
CNTA
|
+$134M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
GPC
HBFP
EH
PIM
DI
TPWA
VC
FIG
Index Venture Life Associates VI's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for Index Venture Life Associates VI, which disclosed 1 position worth $112M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Centessa Pharmaceuticals: 9,961,789 shares worth $112M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Index Venture Life Associates VI's largest Q4 2021 buy was Centessa Pharmaceuticals: 9,961,789 shares worth $112M.
- Index Venture Life Associates VI's ten largest holdings make up 100% of its $112M portfolio in Q4 2021.
- Index Venture Life Associates VI disclosed 1 position in Q4 2021, its first 13F filing on record.
Based on Index Venture Life Associates VI's 13F filing for Q4 2021, filed 14 Feb 2022.